multicent patenc trial intraven anistreplas streptokinas acut myocardi infarct studi investig thrombolyt therapi clinic outcom onset symptom acut myocardi infarct mechan benefit reestablish mainten coronari arteri patenc anistreplas second gener thrombolyt agent long durat action anistreplas min therapi food drug administration-approv regimen intraven streptokinas min double-blind multicent patenc trial patient year age electrocardiograph ST segment elev hour symptom onset coronari patenc blind fashion angiogram earli minut minut hour hour therapi earli total patenc thrombolysi myocardi infarct perfus high anistreplas streptokinas therapi overal patenc pattern similar patent arteri complet perfus anistreplas streptokinas residu coronari stenosi valid computer-assist method patent arteri anistreplas mean stenosi diamet streptokinas patient patent arteri earli intervent reocclus risk day low anistreplas averag coronari perfus grade percent residu stenosi follow-up initi evalu treatment group enzymat electrocardiograph evolut differ group rapid inject anistreplas small mm Hg transient minut differenti fall blood pressur in-hospit mortal rate compar anistreplas streptokinas stroke patient stroke other seriou event advers experi similar frequenc group end point studi patenc safeti anistreplas streptokinas overal favor compar outcom differ abstract truncat AT word 